These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31681581)

  • 1. Risk Factors for Metastasis at Initial Diagnosis With Ewing Sarcoma.
    Ye C; Dai M; Zhang B
    Front Oncol; 2019; 9():1043. PubMed ID: 31681581
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors for metastasis and poor prognosis of Ewing sarcoma: a population based study.
    Shi J; Yang J; Ma X; Wang X
    J Orthop Surg Res; 2020 Mar; 15(1):88. PubMed ID: 32131863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for detectable metastatic disease at presentation in Ewing sarcoma - An analysis of the SEER registry.
    Ramkumar DB; Ramkumar N; Miller BJ; Henderson ER
    Cancer Epidemiol; 2018 Dec; 57():134-139. PubMed ID: 30412903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ewing sarcoma of the pelvis: Clinical features and overall survival
    Brown JM; Rakoczy K; Tokson JH; Jones KB; Groundland JS
    Cancer Treat Res Commun; 2022; 33():100634. PubMed ID: 36126512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
    Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for survival in patients with Ewing's sarcoma using the surveillance, epidemiology, and end results (SEER) program database.
    Duchman KR; Gao Y; Miller BJ
    Cancer Epidemiol; 2015 Apr; 39(2):189-95. PubMed ID: 25595632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for lung metastasis at presentation with malignant primary osseous neoplasms: a population-based study.
    Xie L; Huang W; Wang H; Zheng C; Jiang J
    J Orthop Surg Res; 2020 Jan; 15(1):32. PubMed ID: 31996232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database.
    Miller BJ; Cram P; Lynch CF; Buckwalter JA
    J Bone Joint Surg Am; 2013 Jul; 95(13):e89. PubMed ID: 23824394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of different treatments and other factors on the prognosis of patients with ewing sarcoma.
    Hua K; Hu Y
    Transl Cancer Res; 2020 Mar; 9(3):1931-1946. PubMed ID: 35117540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synovial Sarcoma Is Not Associated With a Higher Risk of Lymph Node Metastasis Compared With Other Soft Tissue Sarcomas.
    Jacobs AJ; Morris CD; Levin AS
    Clin Orthop Relat Res; 2018 Mar; 476(3):589-598. PubMed ID: 29529647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database.
    Schneiderman BA; Kliethermes SA; Nystrom LM
    Clin Orthop Relat Res; 2017 Mar; 475(3):799-805. PubMed ID: 26975384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The patterns of distant metastasis and prognostic factors in patients with primary metastatic Ewing sarcoma of the bone.
    Zhang L; Xiong L; Wu LM; Shen WH; Zhou P; Lian CL; Zhang WT; Wu SG
    J Bone Oncol; 2021 Oct; 30():100385. PubMed ID: 34401227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Ewing sarcoma of the head and neck: A retrospective survival analysis.
    Martin E; Radomski S; Harley EH
    Int J Pediatr Otorhinolaryngol; 2019 Feb; 117():138-142. PubMed ID: 30579068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model: A multistate model for Ewing sarcoma.
    Bosma SE; Rueten-Budde AJ; Lancia C; Ranft A; Dirksen U; Krol AD; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Fiocco M
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27943. PubMed ID: 31389188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical features and outcomes in patients with extraskeletal vs skeletal Ewing sarcoma: an SEER database analysis of 3,178 cases.
    Jiang S; Wang G; Chen J; Dong Y
    Cancer Manag Res; 2018; 10():6227-6236. PubMed ID: 30538569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine.
    Arshi A; Sharim J; Park DY; Park HY; Yazdanshenas H; Bernthal NM; Shamie AN
    Spine J; 2017 May; 17(5):645-655. PubMed ID: 27856382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of regional lymph node (RLN) metastasis among patients with bone sarcoma and survival of patients with RLN-positive bone sarcoma.
    Dong Y; Wu W; Kang H; Xiong W; Ye D; Fang Z; Guan H; Liao H; Li F
    Ann Transl Med; 2021 Jan; 9(1):48. PubMed ID: 33553341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival Outcomes in Metastatic Ewing Sarcoma Treated With Whole-Lung Radiation.
    Dang A; Feng X; Hamm J; Holloway CL; Truong PT
    Cureus; 2022 Jul; 14(7):e26750. PubMed ID: 35967186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Features and Prognostic Factors in Elderly Ewing Sarcoma Patients.
    Liu HF; Wang JX; Zhang DQ; Lan SH; Chen QX
    Med Sci Monit; 2018 Dec; 24():9370-9375. PubMed ID: 30580374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry.
    Lee J; Hoang BH; Ziogas A; Zell JA
    Cancer; 2010 Apr; 116(8):1964-73. PubMed ID: 20151425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.